Cargando…

Everolimus in combination with octreotide LAR in thymic atypical carcinoid

Thymic atypical carcinoids are extremely rare tumors and have a poor prognosis owing to their aggressive clinical course. The efficacy of treatments other than complete surgical resection is unclear. We herein report a postoperative recurrent case of thymic atypical carcinoid treated with everolimus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakane, Tadashi, Nakano, Tomoharu, Hagui, Emi, Haneda, Hiroshi, Okuda, Katsuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2023
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212656/ https://www.ncbi.nlm.nih.gov/pubmed/37037489 http://dx.doi.org/10.1111/1759-7714.14887

Ejemplares similares

A case of resected pulmonary capillary hemangioma with a literature review
por: Hagui, Emi, et al.
Publicado: (2023)

Metastatic Recurrence of Typical Pulmonary Carcinoid Accompanied by Carcinoid Syndrome, Successfully Treated with Octreotide LAR
por: Yanagisawa, Asako, et al.
Publicado: (2017)

Thymic inflammatory pseudotumor with multilocular thymic cyst caused by immunoglobulin G4‐related disease
por: Oda, Risa, et al.
Publicado: (2018)

Metastatic thymic carcinoid responds to chemoradiation and octreotide: A case report
por: Mei, Zhu, et al.
Publicado: (2018)

Clinical remission of an inoperable malignant insulinoma by the combination treatment with octreotide and everolimus
por: Akahori, Hiroshi
Publicado: (2019)

Citalopram/octreotide: Carcinoid heart disease, unmasking of carcinoid syndrome and development of octreotide resistance: case report
Publicado: (2021)

Atypical Thymic Carcinoid in a Patient with Zollinger-Ellison Syndrome
por: Lee, Jiyun, et al.
Publicado: (2019)

A single-center analysis of 71 patients with thymic carcinoma: the chronological changes in the surgical procedure and prognosis
por: Yokota, Keisuke, et al.
Publicado: (2022)

Invasive atypical thymic carcinoid: three case reports and literature review
por: Zhu, Shan, et al.
Publicado: (2016)

Pigmented spindle cell variant of a thymic atypical carcinoid in an octogenarian
por: Sakamaki, Yasushi, et al.
Publicado: (2021)

A case of atypical thymic carcinoid mimicking a paraganglioma
por: Yasukawa, Motoaki, et al.
Publicado: (2020)

Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study
por: Kirzinger, Lukas, et al.
Publicado: (2016)

Octreotide s.c. depot provides sustained octreotide bioavailability and similar IGF-1 suppression to octreotide LAR in healthy volunteers
por: Tiberg, Fredrik, et al.
Publicado: (2015)

Ectopic Cushing’s syndrome due to adrenocorticotropic hormone secreting atypical thymic carcinoid tumor
por: Duran, Cevdet, et al.
Publicado: (2018)

Simultaneous surgical resection of cardiac myxoma and atypical thymic carcinoid: a case report
por: Matsushima, Ryohei, et al.
Publicado: (2021)

A comparative study of PD-L1 immunohistochemical assays with four reliable antibodies in thymic carcinoma
por: Sakane, Tadashi, et al.
Publicado: (2018)

An operated case of locally advanced thymic atypical carcinoid in anterior mediastinum: a case report
por: Zhang, Kai, et al.
Publicado: (2020)

Paraneoplastic Neuromyelitis Optica Spectrum Disorder Associated with Atypical Thymic Carcinoid: A Case Report
por: Mitsui, Suguru, et al.
Publicado: (2021)

Efficacy and safety of everolimus treatment in a hemodialysis patient with metastatic atypical bronchial carcinoid: case report and literature review
por: Brizzi, M. P., et al.
Publicado: (2018)

Blastomatoid pulmonary carcinosarcoma: A rare case report and review of the literature
por: Sakane, Tadashi, et al.
Publicado: (2018)

Mixed‐type primary germ cell tumor of the mediastinum in a young adult male with a sudden life threatening condition: A case report
por: Sakane, Tadashi, et al.
Publicado: (2019)

Prognostic value of systemic inflammatory markers and the nutrition status in thymic epithelial tumors with complete resection
por: Sakane, Tadashi, et al.
Publicado: (2022)

Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma in vitro
por: Graillon, Thomas, et al.
Publicado: (2017)

Metastatic hepatic carcinoid associated with ectopic ACTH syndrome, resistant to octreotide and ketoconazole therapy
por: Khan, Mohammed Qassim, et al.
Publicado: (2004)

Pharmacokinetic and technical comparison of Sandostatin(® )LAR(® )and other formulations of long-acting octreotide
por: Petersen, Holger, et al.
Publicado: (2011)

Comparison of octreotide LAR and lanreotide autogel as post-operative medical treatment in acromegaly
por: Tutuncu, Yasemin, et al.
Publicado: (2011)

Successful Pregnancies after the Treatment of a Thymic Carcinoid
por: Tjalma, Wiebren A. A.
Publicado: (2015)

Thymic carcinoid tumor combined with thymoma--neuroendocrine differentiation in thymoma?
por: Cho, K. J., et al.
Publicado: (1993)

Thymic atypical carcinoid tumors with elevated mitotic counts in a patient with multiple endocrine neoplasia: A case report
por: Hiro, Shuntaro, et al.
Publicado: (2023)

Diabetes Insipidus Induced by Combination of Short-acting Octreotide and Lanreotide for Recurrent Carcinoid Crisis of Neuroendocrine Tumour: A Case Report
por: Guan, Goh Kian, et al.
Publicado: (2021)

Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
por: Nilsson, O., et al.
Publicado: (1998)

A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR® (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly
por: Mercado, Moises, et al.
Publicado: (2007)

Atypical diagnosis for typical lung carcinoid
por: Piro, Roberto, et al.
Publicado: (2019)

Pleural Metastasis of Atypical Bronchial Carcinoid
por: Zinchenko, Eugeniy Igorevich, et al.
Publicado: (2020)

Predictive factors of antiproliferative activity of octreotide LAR as first-line therapy for advanced neuroendocrine tumours
por: Laskaratos, Faidon-Marios, et al.
Publicado: (2016)

Uneventful octreotide LAR therapy throughout three pregnancies, with favorable delivery and anthropometric measures for each newborn: a case report
por: Naccache, Deeb Daoud, et al.
Publicado: (2011)

Primary thymic atypical carcinoid with rare multiple bone metastasis: A case report and literature review
por: Rao, Xinrui, et al.
Publicado: (2021)

Solitary late metastasis of primary renal cell carcinoid tumor to the extraocular muscles imaged with indium-111 octreotide
por: Dempsey, Philip Jude, et al.
Publicado: (2020)

Lanreotide vs octreotide LAR for patients with advanced gastroenteropancreatic neuroendocrine tumors: An observational time and motion analysis
por: Ryan, P, et al.
Publicado: (2019)

Population Pharmacokinetic Modelling of the Complex Release Kinetics of Octreotide LAR: Defining Sub-Populations by Cluster Analysis
por: Kapralos, Iasonas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_icmf9bj3vh7c46o2vtho0tbmo1